Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.

about

The rapid spread of carbapenem-resistant Enterobacteriaceae.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

P2860

Q39027434-DDF4CE97-7220-4A3B-877B-040F1B7C44AD Q52695014-DA94F5E9-5053-4126-BF44-3DC51AFAC723

P2860

Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.

Item

http://www.wikidata.org/entity/Q40662901

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Modeling Meropenem Treatment, ...... Unusually Low Carbapenem MICs.

@en

type

Item

label

Modeling Meropenem Treatment, ...... Unusually Low Carbapenem MICs.

@en

prefLabel

Modeling Meropenem Treatment, ...... Unusually Low Carbapenem MICs.

@en

P1476

Modeling Meropenem Treatment, ...... Unusually Low Carbapenem MICs

@en

P2093

A Corso

http://www.w3.org/2001/XMLSchema#string

F Pasteran

http://www.w3.org/2001/XMLSchema#string

J Gu

http://www.w3.org/2001/XMLSchema#string

L Paz

http://www.w3.org/2001/XMLSchema#string

M Fatouraei

http://www.w3.org/2001/XMLSchema#string

P Gagetti

http://www.w3.org/2001/XMLSchema#string

R Fernandez

http://www.w3.org/2001/XMLSchema#string

W E Rose

http://www.w3.org/2001/XMLSchema#string

P2860

Carbapenem resistance in Enterobacteriaceae: here is the storm!

Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.

Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.

Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae

The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens.

Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity

P304

5047-5050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00168-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adriana E. Rosato

Maria P. Martinez

P577

2016-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27216067

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

carbapenem antibiotic

P932

4958156

http://www.w3.org/2001/XMLSchema#string

Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.

about

P2860

P2860

Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932